OTC diaper rash products
This article was originally published in The Tan Sheet
Executive Summary
Compliance bulletin issued to the field on May 21 notes that "the use of any active external analgesic ingredient and/or topical antifungal ingredient in a product offered to treat and/or prevent diaper rash introduced . . . into interstate commerce" after June 17 without an approved NDA will be in violation of the FD&C Act. The final rules for external analgesics and topical antifungals used for diaper rash were published Dec. 18, 1992 and go into effect on June 18. The bulletin lists several products for diaper rash, including Fisons' Caldesene Medicated Powder and Ointment, Fleming's Impregon, Sween's Sween Cream, Macsil's Balmex Baby Powder, and Innotek's Bottom Better.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning